Haemonetics (HAE) Ownership - Who Owns Haemonetics?

432 Followers

Haemonetics (HAE) Ownership Overview

1.84% Insiders

37.20% Mutual Funds

19.27% Other Institutional Investors

28.26% ETFs

13.43% Public Companies and

Individual Investors

The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 84.73% of the company’s stock is owned by Institutional Investors, 1.84% is owned by Insiders, and 13.43% is owned by Public Companies and Individual Investors.

The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 56.47% of the company’s stock is owned by Institutional Investors, 1.84% is owned by Insiders, and 28.26% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Nov 12, 2025	Mark Kroll	xxxxxxxxxxxxx	$98784

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$2726528
Mar 31, 2024	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$320745
Mar 31, 2024	Hussman Strategic Advisors Inc	xxxxxxxxxxxxx	$591780
Mar 31, 2024	Blackstone Inc.	xxxxxxxxxxxxx	$360704

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	5,154,677	Institution	11.34%	367,425,377
	4,320,530	Institution	9.51%	307,967,378
	3,753,193	Institution	8.26%	267,527,597
	3,719,710	Institution	8.18%	265,140,929
	972,988	Institution	2.14%	69,354,585
	965,513	Institution	2.12%	68,821,767
	862,690	Institution	1.90%	61,492,543
	663,442	Institution	1.46%	47,290,146
Ken Fisher	662,504	Institution	1.46%	47,223,285
	640,201	Institution	1.41%	45,633,527

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
3,753,193	Institution	8.26%	267,527,597
3,719,710	Institution	8.18%	265,140,929
972,988	Institution	2.14%	69,354,585
862,690	Institution	1.90%	61,492,543
640,201	Institution	1.41%	45,633,527
612,960	Institution	1.35%	43,691,789
530,682	Institution	1.17%	37,827,013
508,451	Institution	1.12%	36,242,387
363,531	Institution	0.80%	25,912,490
345,956	Institution	0.76%	24,659,744

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Core S&P Mid-Cap ETF	1,580,321	Institution	3.48%	112,645,281
iShares S&P Mid-Cap ETF CDI	1,567,099	Institution	3.45%	121,152,424
Vanguard Total Stock Market ETF	1,492,664	Institution	3.28%	89,694,180
iShares Russell 2000 ETF	1,096,777	Institution	2.41%	78,178,265
Vanguard Small-Cap ETF	1,071,064	Institution	2.36%	64,360,236
Vanguard Extended Market ETF	524,168	Institution	1.15%	31,497,255
iShares Russell 2000 Growth ETF	386,229	Institution	0.85%	27,530,403
SPDR S&P Midcap 400 ETF Trust	352,419	Institution	0.78%	25,120,426
Vanguard Small Cap Value ETF	344,285	Institution	0.76%	20,688,086
Vanguard Small-Cap Growth ETF	299,190	Institution	0.66%	17,978,327

FAQ

Who Owns Haemonetics (HAE)?

According to the latest TipRanks data, approximately 19.27% of the company's stock is held by institutional investors, 1.84% is held by insiders, and 13.43% is held by retail investors.

What percentage of Haemonetics (HAE) stock is held by institutional investors?

According to the latest TipRanks data, approximately 19.27% of Haemonetics (HAE) stock is held by institutional investors.

What percentage of Haemonetics (HAE) stock is held by retail investors?

According to the latest TipRanks data, approximately 13.43% of Haemonetics (HAE) stock is held by retail investors.

Who owns the most shares of Haemonetics (HAE)?

iShares owns the most shares of Haemonetics (HAE).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.